Evidence map›Paper›PMID 27793335›Full record

ArticleCellular immunology2017

Role of heterogeneous cell population on modulation of dendritic cell phenotype and activation of CD8 T cells for use in cell-based immunotherapies.

Hannah Frizzell, Jaehyung Park, Natacha Comandante Lou, Kim A Woodrow

Open access · greenAbstract read
In one paragraph

Article in Cellular immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Flt3-L enhances trans-epithelial migration and antigen presentation of dendritic cells adoptively transferred to genital mucosa.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hannah FrizzellDepartment of Bioengineering, University of Washington, 3720 15th Ave NE, Seattle, WA 98105, USA.
Jaehyung ParkDepartment of Bioengineering, University of Washington, 3720 15th Ave NE, Seattle, WA 98105, USA.
Natacha Comandante LouDepartment of Bioengineering, University of Washington, 3720 15th Ave NE, Seattle, WA 98105, USA.
Kim A WoodrowDepartment of Bioengineering, University of Washington, 3720 15th Ave NE, Seattle, WA 98105, USA. Electronic address: woodrow@uw.edu.
University of Washington · US

Funding

Nanomaterials for engineering protection in the genital mucosaDP2HD075703 · NICHD · UNIVERSITY OF WASHINGTON · PI WOODROW, KIM A. · 2012 to 2012
$2.3M
NICHD NIH HHS DP2 HD075703
6 · The paper itself

Abstract

Dendritic cell (DC)-based immunotherapies have much utility in their ability to prime antigen-specific adaptive immune responses. However, there does not yet exist a consensus standard to how DCs should be primed. In this study, we aimed to determine the role of heterogeneous co-cultures, composed of both CD11c+ (DCs) and CD11c- cells, in combination with monophosphoryl lipid A (MPLA) stimulation on DC phenotype and function. Upon DC priming in different co-culture ratios, we observed reduced expression of MHCII and CD86 and increased antigen uptake among CD11c+ cells in a CD11c- dependent manner. DCs from all culture conditions were induced to mature by MPLA treatment, as determined by secretion of pro-inflammatory cytokines IL-12 and TNF-α. Antigen-specific stimulation of CD4+ T cells was not modulated by co-culture composition, in terms of proliferation nor levels of IFN-γ. However, the presence of CD11c- cells enhanced cross-presentation to CD8+ T cells compared to purified CD11c+ cells, resulting in increased cell proliferation along with higher IFN-γ production. These findings demonstrate the impact of cell populations present during DC priming, and point to the use of heterogeneous cultures of DCs and innate immune cells to enhance cell-mediated immunity.

Indexed as

Immunity, InnateAnimalsCD11c AntigenCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationCell ProliferationCells, CulturedCoculture TechniquesCross-PrimingDendritic CellsFemaleImmunity, CellularImmunotherapyInterferon-gammaInterleukin-12CD11c AntigenInterferon-gammaInterleukin-12Lipid Amonophosphoryl lipid ATumor Necrosis Factor-alphaBone marrowCell activationDendritic cellsImmunotherapyPriming protocolT cellsToll-like receptors (TLRs)

Identifiers

PMID27793335
PMCPMC5283719
OpenAlexW2530476503

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.